| A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS) (NCT05348681) | Aristea Therapeutics, Inc. | 2022-07-18 |
| Replicative Stress in Hair Follicle Stem Cells and Pathogeny of Hidradenitis Suppurativa (NCT05531747) | Assistance Publique - Hôpitaux de Paris | 2022-06-13 |
| Botulinum Toxin Therapy in Hidradenitis Suppurativa (NCT05403710) | University of Massachusetts, Worcester | 2022-06-07 |
| Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa (NCT05020730) | Phoenicis Therapeutics | 2022-05-05 |
| Hidradenitis Suppurativa Phase 2b Study of Izokibep (NCT05355805) | ACELYRIN Inc. | 2022-05-05 |
| JAK-STAT Signaling Pathway in Pyoderma Gangrenosum (NCT04792957) | Dokuz Eylul University | 2022-05-01 |
| Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa (NCT05322473) | MoonLake Immunotherapeutics AG | 2022-04-25 |
| Wet-to-dry vs Petrolatum & Non-stick Dressings After Hidradenitis Suppurativa Surgery (NCT05194969) | University of North Carolina, Chapel Hill | 2022-04-25 |
| Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa (NCT04582669) | Montefiore Medical Center | 2022-01-24 |
| Myriad™ Augmented Soft Tissue Reconstruction Registry (NCT05243966) | Aroa Biosurgery Limited | 2022-01-10 |
| ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS) (NCT05216224) | Aclaris Therapeutics, Inc. | 2021-12-29 |
| A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy (NCT05139602) | AbbVie | 2021-12-28 |
| Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa (NCT04989517) | Azora Therapeutics Australia Pty Ltd | 2021-11-23 |
| A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (NCT04988308) | Janssen Research & Development, LLC | 2021-10-12 |
| A Bioelectric Dressing for Post De-Roofing Treatment of HS (NCT05057429) | University of Miami | 2021-10-11 |
| Study of the Effect of Fostamatinib Upon Cutaneous Inflammation in the Setting of Hidradenitis Suppurativa (NCT05040698) | Holdsworth House Medical Practice | 2021-10-01 |
| A Double-blind Placebo-controlled Randomized Trial Evaluating the Efficacy and Safety of a Novel HSP90 Inhibitor (RGRN-305) in the Treatment of Moderate to Severe Hidradenitis Supppurativa. (NCT05286567) | Aarhus University Hospital | 2021-09-01 |
| A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial (NCT04876391) | Boehringer Ingelheim | 2021-08-24 |
| Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) (NCT05093855) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2021-08-18 |
| Molecular Characteristics of Brodalumab in Hidradenitis Suppurativa (NCT04979520) | Rockefeller University | 2021-08-05 |
| A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Hidradenitis Suppurativa (NCT04856930) | Vanda Pharmaceuticals | 2021-07-07 |
| Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) (NCT05103423) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2021-06-24 |
| Bacteriophage Therapy for Difficult-to-treat Infections: the Implementation of a Multidisciplinary Phage Task Force (NCT06368388) | Universitaire Ziekenhuizen KU Leuven | 2021-06-01 |
| A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa (NCT04901195) | UCB Biopharma SRL | 2021-05-27 |
| A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa (NCT04762277) | Boehringer Ingelheim | 2021-04-06 |
| Relationships Among Inflammation, Physical and Mental Health in Subjects With Chronic Inflammatory Physical Diseases. (NCT05125458) | University of Campania Luigi Vanvitelli | 2021-04-01 |
| Allogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis Suppurativa (NCT04541550) | IntegoGen, LLC | 2021-04-01 |
| LTX-109 as Treatment for Hidradenitis Suppurativa (NCT04756336) | Pharma Holdings AS | 2021-03-05 |
| Hidradenitis Suppurativa (HS) Tunneling Wounds (NCT04648631) | University of Miami | 2021-02-26 |
| A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS) (NCT04772885) | Kymera Therapeutics, Inc. | 2021-02-23 |
| Intralesional Diode Laser Treatment of Fistulas in Hidradenitis Suppurativa (NCT04508374) | Zealand University Hospital | 2020-12-10 |
| Tofacitinib for Immune Skin Conditions in Down Syndrome (NCT04246372) | University of Colorado, Denver | 2020-10-21 |
| Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa (NCT04600375) | University of Arkansas | 2020-10-20 |
| Defects of Keratinocytes Function in Dermatologic Patients (NCT06324552) | IRCCS Burlo Garofolo | 2020-10-12 |
| Spironolactone for Hidradenitis Suppurativa (NCT04100083) | Medical University of South Carolina | 2020-09-21 |
| Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa (NCT03929835) | TO Pharmaceuticals | 2020-09-01 |
| A Study of LY3041658 in Adults With Hidradenitis Suppurativa (NCT04493502) | Eli Lilly and Company | 2020-08-26 |
| To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa (NCT04476043) | Incyte Corporation | 2020-08-25 |
| Hidradenitis Suppurativa Patient Experience With Humira Treatment (NCT04132388) | Wake Forest University Health Sciences | 2020-08-20 |
| Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository (NCT04115566) | University of California, San Francisco | 2020-08-01 |
| Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab. (NCT04084665) | Rockefeller University | 2020-06-01 |
| Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atopic Dermatitis (NCT04440410) | Kymera Therapeutics, Inc. | 2020-05-28 |
| Therapeutic Effect of Methalazine on 27 Cases of Suppurative Hidradenitis (NCT06568224) | The First Affiliated Hospital with Nanjing Medical University | 2020-05-01 |
| Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa (NCT04179175) | Novartis Pharmaceuticals | 2020-03-18 |
| A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa (NCT04242498) | UCB Biopharma SRL | 2020-03-02 |
| A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa (NCT04242446) | UCB Biopharma SRL | 2020-02-19 |
| An Alternative Dose Interval Study in Participants With Hidradenitis Suppurativa Receiving Brodalumab (NCT04249713) | Rockefeller University | 2020-02-03 |
| Hidradenitis Suppurativa Written Action Plan (NCT04230291) | University of Arizona | 2020-02-01 |
| Battlefield Acupuncture for Pain in Hidradenitis Suppurativa (NCT04218422) | Wayne State University | 2020-01-22 |
| Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory Diseases (NCT04200690) | University of Aarhus | 2020-01-14 |
| Evaluating the Safety and Efficacy of Laight®-Therapy Treatment in Subjects With Hidradenitis Suppurativa (NCT05927948) | Henry Ford Health System | 2019-11-04 |
| HidraWear Study for Hidradenitis Suppurativa Wounds (NCT04449354) | HidraMed Solutions Ltd | 2019-10-30 |
| Guselkumab for Hidradenitis Suppurativa, a Mode of Action Study. (NCT04061395) | University Medical Center Groningen | 2019-10-01 |
| Hidradenitis - an Analysis of Genetic Traits and Linkages in Families (NCT05710393) | University of Chicago | 2019-09-17 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa (NCT04019041) | Janssen Research & Development, LLC | 2019-09-16 |
| Negative Pressure Wound Therapy With Instillation for Treatment of Hidradenitis Suppurativa (NCT04325607) | Royal Free Hospital NHS Foundation Trust | 2019-09-01 |
| Safety and Efficacy of Laser Therapy in Gynaecology (NCT04073082) | Juna d.o.o. | 2019-07-24 |
| Complement C5a Receptors in Hidradenitis Suppurativa (NCT04251663) | Stanford University | 2019-07-18 |
| Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS (NCT04018599) | Fresenius Kabi SwissBioSim GmbH | 2019-07-15 |
| A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa (NCT03926169) | AbbVie | 2019-06-03 |
| Biomarkers In Hidradenitis Suppurativa Participants Receiving Brodalumab (NCT03960268) | Rockefeller University | 2019-05-28 |
| Treatment of Moderate Hidradenitis Suppurativa (NCT03910803) | Florida Academic Dermatology Centers | 2019-05-01 |
| Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa (NCT03827798) | Novartis Pharmaceuticals | 2019-02-27 |
| Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS) (NCT03713632) | Novartis Pharmaceuticals | 2019-02-25 |
| A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC (NCT03661866) | Target PharmaSolutions, Inc. | 2018-12-21 |
| Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) (NCT03852472) | Amgen | 2018-12-21 |
| A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa (NCT03607487) | Incyte Corporation | 2018-10-15 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS) (NCT03628924) | Janssen Research & Development, LLC | 2018-09-04 |
| Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS (NCT03221621) | Erasmus Medical Center | 2018-07-31 |
| A Study of Bermekimab in Patients With Hidradenitis Suppurativa (NCT03512275) | Janssen Research & Development, LLC | 2018-06-20 |
| Hidradenitis Suppurativa and Periodontal Diseases (NCT03553888) | CHU de Reims | 2018-05-07 |
| A Single Center, Prospective Clinical Trial of Intravenous Ertapenem in the Treatment of Hurley Stage II or III Hidradenitis Suppurativa (NCT05255575) | Henry Ford Health System | 2018-03-01 |
| Safety and Treatment of Cryoinsufflation in Treatment of Hidradenitis Suppurativa (NCT05830149) | Henry Ford Health System | 2018-02-20 |
| Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa (NCT03275870) | Elena Gonzalez Brant, MD | 2017-09-28 |
| A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa. (NCT03248531) | UCB Biopharma SRL | 2017-09-22 |
| Microwave Ablation in Mild Axillary Hidradenitis Suppurativa (NCT03238469) | M.B.A. van Doorn | 2017-09-01 |
| Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin (NCT05066113) | Johns Hopkins University | 2017-08-15 |
| Intense Pulsed Light Therapy for Hidrosadenitis Suppurativa (NCT03203122) | Zealand University Hospital | 2017-08-07 |
| Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions (NCT03198390) | University of Arizona | 2017-08-04 |
| Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa (NCT03103074) | University Hospital of North Norway | 2017-06-01 |
| Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite Laser (NCT03054155) | Wayne State University | 2017-05-11 |
| The Ohio State University Dermatology Biorepository (NCT03146676) | Ohio State University | 2017-04-19 |
| Low Dose Radiotherapy for Advanced Hidradenitis Suppurativa (NCT03040804) | Montefiore Medical Center | 2017-03-01 |
| Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis (NCT03049267) | M.B.A. van Doorn | 2017-02-02 |
| Studying Complement Inhibition in Patients With Moderate to Severe Hidradenitis Suppurativa (NCT03001622) | InflaRx GmbH | 2016-12-01 |
| Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa (NCT02904902) | AbbVie | 2016-09-06 |
| Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa (NCT02805595) | Beth Israel Deaconess Medical Center | 2016-08-01 |
| Clinical and Biological Characteristics of Hidradenitis Suppurativa (NCT03967600) | University of California, San Francisco | 2016-07-15 |
| Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa (NCT03099980) | Tufts Medical Center | 2016-07-11 |
| Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting (NCT02786576) | AbbVie | 2016-07-05 |
| Single Center Study of Apremilast for the Treatment of Hidradenitis Suppurativa (NCT02695212) | Florida Academic Dermatology Centers | 2016-07-01 |
| A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa. (NCT02781818) | University of North Carolina, Chapel Hill | 2016-06-01 |
| Post Marketing Observational Study (PMOS) to Assess Quality of Life in Swedish Hidradenitis Suppurativa (HS) Patients (NCT02739828) | AbbVie | 2016-04-07 |
| MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMAB (NCT02643654) | Evangelos J. Giamarellos-Bourboulis, M.D. | 2015-12-01 |
| A National Registry For Patients With Hidradenitis Suppurativa (NCT03289585) | Montefiore Medical Center | 2015-08-01 |
| Nutritional Status and Hidradenitis Suppurativa (Acne Inversa) (NCT03683238) | Federico II University | 2015-05-01 |
| Impact of Hidradenitis Suppurativa on Quality of Life Functions (NCT03288337) | Montefiore Medical Center | 2015-04-01 |
| Quality of Life After Wide Surgical Excision in Patients With Hidradenitis Suppurativa (NCT02593604) | University Hospital Schleswig-Holstein | 2015-03-15 |
| Activation of a Cutaneous Inflammasome in the Skin of Hidradenitis Suppurativa Patients (NCT02833909) | CHU de Reims | 2015-03-01 |
| Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing (NCT02163746) | Henry Ford Health System | 2015-01-14 |